We are a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.
CORE STRENGTHS OF BIOSION
WORLD-CLASS TEAM
Experienced global leaders from multinational companies who have brought more than 20 Innovative biologics to the market worldwide. Management team with proven track record of generating $5B+ in partnering R&D and commercial revenue.
We are a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.